Inventor · disambiguated record
Sarah S. Bacus
Also filed as: BACUS SARAH · BACUS SARAH S
16 granted patents·27 pending applications·539 citations·filing 1992–2022
94Inventor score
Files withBACUS SARAH9VENTANA MED SYST INC8BACUS SARAH S5TARGETED MOLECULAR DIAGNOSTICS4TARGETED MOLECULAR DIAGNOSTICS LLC3
Top patents by PatentIndex Score
43 records- 0195US5514554AMethods and compositions for cancer therapy and for prognosticating responses to cancer therapyBECTON DICKINSON CO·Filed 1992·Granted May 7, 1996·177 cites·17 claims
- 0294US5252487AMethod and apparatus for determining the amount of oncogene protein product in a cell sampleCELL ANALYSIS SYSTEMS INC·Filed 1993·Granted Oct 12, 1993·103 cites·6 claims
- 0393US5288477AMethod for prognosticating response to cancer therapyBECTON DICKINSON CO·Filed 1993·Granted Feb 22, 1994·131 cites·17 claims
- 0492US7419777B2Method and quantification assay for determining c-kit/SCF/pAKT statusVENTANA MED SYST INC·Filed 2002·Granted Sep 2, 2008·48 cites·23 claims
- 0591US8512967B2Method for predicting the response to HER2-directed therapyBACUS SARAH S·Filed 2011·Granted Aug 20, 2013·16 cites·12 claims
- 0690US8946256B2Compositions and methods for treatment of vitiligoBACUS SARAH·Filed 2012·Granted Feb 3, 2015·9 cites·16 claims
- 0790US7771958B2Method for predicting response to epidermal growth factor receptor-directed therapyAMGEN INC·Filed 2006·Granted Aug 10, 2010·12 cites·14 claims
- 0886US6962789B2Method for quantitating a protein by image analysisVENTANA MED SYST INC·Filed 2001·Granted Nov 8, 2005·29 cites·18 claims
- 0982US7862995B2Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitorTARGETED MOLECULAR DIAGNOSTICS·Filed 2005·Granted Jan 4, 2011·12 cites·11 claims
- 1070US2019219581A1Method for predicting the response to her2-directed therapyVENTANA MED SYST INC·Filed 2019·Application pending·0 cites
- 1166US2018031559A1Method for predicting the response to her2-directed therapyVENTANA MED SYST INC·Filed 2017·Application pending·0 cites
- 1265US9625446B2Method and quantification assay for determining c-kit/SCF/pAKT statusBACUS SARAH S·Filed 2007·Granted Apr 18, 2017·1 cites·8 claims
- 1362US9239331B2Method for predicting the response to HER2-directed therapyVENTANA MED SYST INC·Filed 2015·Granted Jan 19, 2016·0 cites·8 claims
- 1462US8956822B2Method for predicting the response to HER2-directed therapyVENTANA MED SYST INC·Filed 2013·Granted Feb 17, 2015·0 cites·5 claims
- 1562US2025059584A1Methods for diagnosing and/or treating alzheimer's diseaseSEQ BIOMARQUE LLC·Filed 2022·Application pending·0 cites
- 1661US2016091493A1Method for predicting the response to her2-directed therapyCELL SIGNALING TECHNOLOGY INC·Filed 2015·Application pending·0 cites
- 1756US7833698B2Method for determining the response to cancer therapyVENTANA MED SYST INC·Filed 2001·Granted Nov 16, 2010·1 cites·16 claims
- 1856US2004132097A1Method for predicting response to epidermal growth factor receptor-directed therapyFiled 2003·Application pending·0 cites
- 1956US2013288285A1Methods for predicting cardiac toxicityTARGETED MOLECULAR DIAGNOSTICS LLC·Filed 2013·Application pending·0 cites
- 2054US8709738B2Methods for predicting cardiac toxicityBACUS SARAH S·Filed 2007·Granted Apr 29, 2014·0 cites·17 claims
- 2154US2010279323A1Method for predicting response to epidermal growth factor receptor-directed therapyAMGEN INC·Filed 2010·Application pending·0 cites
- 2253US2005106639A1Method for quantification of AKT protein expressionUNIV ILLINOIS·Filed 2004·Application pending·0 cites
- 2350US2004248151A1Method for predicting the response to HER2-directed therapyVENTANA MED SYST INC·Filed 2003·Application pending·0 cites
- 2449US2023314408A1Immune profiling and methods of using same to predict responsiveness to an immunotherapy and treat cancerGOPATH LABORATORIES LLC·Filed 2021·Application pending·0 cites
- 2549US2015098932A1Compositions and methods for treatment of vitiligoBACUS SARAH·Filed 2014·Application pending·0 cites
- 2647US2007059785A1Biomarkers in cancerSMITHKLINE BEECHAM CORP·Filed 2004·Application pending·0 cites
- 2746US8623604B2Methods for predicting responsiveness of a cancer cell to an anti-IGFR1 antibody by analysis of mutations in PIK3CABACUS SARAH·Filed 2010·Granted Jan 7, 2014·0 cites·26 claims
- 2846US2002015974A1Method for quantification of AKT protein expressionFiled 2001·Application pending·0 cites
- 2945US10851422B2Methods of determining an immune response scoreAMERICAN MOLECULAR LABORATORIES INC·Filed 2017·Granted Dec 1, 2020·0 cites·10 claims
- 3044US2010173918A1Methods and compositions for determining the efficacy of breast cancer therapeuticsTARGETED MOLECULAR DIAGNOSTICS·Filed 2008·Application pending·0 cites
- 3144US2013225424A1Methods for determining responsiveness to a drug based upon determination of ras mutation and/or ras amplificationBACUS SARAH S·Filed 2011·Application pending·0 cites
- 3243US2010303809A1Methods for the detection and quantitation of ptenTARGETED MOLECULAR DIAGNOSTICS LLC·Filed 2010·Application pending·0 cites
- 3343US2009318346A1BIVALENT ErbB LIGAND BINDING MOLECULES AND METHODS FOR THEIR PREPARATION AND USETARGETED MOLECULAR DIAGNOSTICS·Filed 2007·Application pending·0 cites
- 3443US2011150856A1Compositions and methods for treatment of vitiligoBACUS SARAH·Filed 2010·Application pending·0 cites
- 3543US2015202187A1Compositions and methods for treatment of vitiligoBACUS SARAH·Filed 2013·Application pending·0 cites
- 3643US2008050757A1Rapid method for detecting mutated genesBACUS SARAH·Filed 2006·Application pending·0 cites
- 3742US2011150798A1Compositions and methods for increasing cellular far and bleaching skinBACUS SARAH·Filed 2010·Application pending·0 cites
- 3842US2006094068A1Predictive markers in cancer therapyBACUS SARAH S·Filed 2003·Application pending·0 cites
- 3941US2015148244A1Methods for determining responsiveness to a dihydrofolate reductase inhibitorBACUS SARAH·Filed 2012·Application pending·0 cites
- 4039US2009214576A1Tyrosine kinase inhibitor compositions and methods for manufacturing and using them in the treatment of diseaseTARGETED MOLECULAR DIAGNOSTICS·Filed 2006·Application pending·0 cites
- 4137US2011059081A1Methods and compositions for the treatment of receptor tyrosine kinase mediated diseases or disordersQUINTILES TRANSNAT CORP·Filed 2010·Application pending·0 cites
- 4236US2010332417A1Methods for the detection and quantitation of the p95 component of her2/neu (erbb2)TARGETED MOLECULAR DIAGNOSTICS LLC·Filed 2010·Application pending·0 cites
- 4329US2016220636A1Method of treating auto-immune or inflammatory diseases using b7 family proteins of derivatives thereofBACUS SARAH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sarah S. Bacus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →